Siemens Healthineers has received Food and Drug Administration clearance for two multifunctional imaging platforms for radiography and fluoroscopy, or real-time 2D imaging: the remote-controlled Luminos Q.namix R and the Luminos Q.namix T with tableside control. The two new platforms, which can be used for specialized and complex examinations, can simplify workflows at low patient radiation doses through intuitive controls, integrated components, and built-in workflow guidance supported by artificial intelligence (AI). This enhanced efficiency can enable faster procedures, reducing patient wait times and increasing overall productivity.
鈥淲ith these two new platforms, Siemens Healthineers offers the radiography and fluoroscopy communities a long-sought, user-friendly alternative to imaging systems of unnecessarily complex design, which have been a barrier to more efficient workflows,鈥 said Niral Patel, head of X-ray Products at Siemens Healthineers North America.
Unlike many 2-in-1 rad/fluoro systems, the Luminos Q.namix platforms have a fully integrated, highly intuitive design, which Siemens Healthineers developed over a six-year period with input from more than 160 customers who are fluoroscopy experts. Both platforms feature ergonomic controls and a streamlined touch interface with automated functions for dose and workflow optimization. Functionalities with live camera and AI support enable users to acquire images of consistent quality at a low radiation dose, regardless of their experience level. The new generation of wireless detectors can improve imaging of microstructures in radiography and works with compatible Siemens Healthineers systems and imaging software.
The remote-controlled Luminos Q.namix R can be operated either in the control room to avoid user radiation exposure, or from inside the exam room at the bedside, depending on patient and exam requirements. It is designed for fluoroscopy procedures that include lower and upper gastrointestinal exams, as well as swallow and joint injection studies that require contrast media. It also can be used for radiography exams, including general exams of the chest, bones, and joints; and orthopedic imaging, including automated long leg and long spine imaging. The Luminos Q.namix R鈥檚 source-to-image distance (SID) of 180 cm (71 inches) can increase productivity during radiography exams by reducing geometrical distortions caused by the distance between the X-ray tube and detector. The in-room control panel allows the user to operate the system adjacent to the patient table, which can be particularly beneficial for pediatric patients and during certain types of fluoroscopy exams.
The Luminos Q.namix T with tableside control is ideal for non-ambulatory patients and examinations that require intensive patient interaction, including pediatrics, bariatrics, and gastroenterology. Multiple touch panels provide easy access to imaging parameters, while the OptiGrip ergonomic handle lets users save fluoro images or loops without diverting their attention from the task at hand. The digital fluoro tower parks automatically, allowing seamless switching between radiographic and fluoroscopic exams.
A copy of the press release and a press picture are available here.
Additional information on the Luminos Q.namix platforms can be found here:
Media contact
Jeff Bell
Phone: (484) 868-8346
Email: jeffrey.t.bell@siemens-healthineers.com
Visit the 聽Siemens Healthineers Press Center
Siemens Healthineers聽pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around 鈧22.4 billion. Further information is available at .
